BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9937)

  • 1. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat brain. Evidence for an activator deficient form.
    Lindl T; Chapman G
    Biochem Biophys Res Commun; 1976 Aug; 71(4):1273-82. PubMed ID: 9937
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal changes in Ca2+/protein activator-dependent and-independent cyclic AMP phosphodiesterase during the development of chick embryos.
    Tanigawa Y; Shimoyama M; Tai J; Fujii K; Ueda I
    Biochem Biophys Res Commun; 1976 Nov; 73(1):19-24. PubMed ID: 187189
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase.
    Cheung WY; Bradham LS; Lynch TJ; Lin YM; Tallant EA
    Biochem Biophys Res Commun; 1975 Oct; 66(3):1055-62. PubMed ID: 170936
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium and papaverine interaction with soluble cardiac phosphodiesterase.
    Carpenedo F; Gaion RM; Fassina G
    Biochem Pharmacol; 1975 Nov; 24(22):2069-73. PubMed ID: 174573
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterases of rabbit renal cortex. Characterization of brush border membrane activities.
    Filburn CR; Sacktor B
    Arch Biochem Biophys; 1976 May; 174(1):249-61. PubMed ID: 7201
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniques.
    Van Inwegen RG; Pledger WJ; Strada SJ; Thompson WJ
    Arch Biochem Biophys; 1976 Aug; 175(2):700-9. PubMed ID: 183123
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
    Levin RM; Weiss B
    Mol Pharmacol; 1977 Jul; 13(4):690-7. PubMed ID: 18661
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of cyclic nucleotide phosphodiesterases from rat brain by activator protein, proteolytic enzymes and a vitamin E derivative.
    Sakai T; Yamanaka H; Tanaka R; Makino H; Kasai H
    Biochim Biophys Acta; 1977 Jul; 483(1):121-34. PubMed ID: 195621
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ; Drummond GI
    J Cyclic Nucleotide Res; 1975; 1(4):219-28. PubMed ID: 177462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates.
    Brostrom CO; Wolff DJ
    Arch Biochem Biophys; 1976 Jan; 172(1):301-11. PubMed ID: 175742
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of the high Km cyclic nucleotide phosphodiesterase of adrenal medulla by the endogenous calcium-dependent-protein activator.
    Uzunov P; Gnegy ME; Revuelta A; Costa E
    Biochem Biophys Res Commun; 1976 May; 70(1):132-8. PubMed ID: 179545
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal medullary cyclic nucleotide phosphodiesterase: lack of activation by the calcium-dependent regulator.
    Egrie JC; Siegel FL
    Biochem Biophys Res Commun; 1975 Nov; 67(2):662-9. PubMed ID: 173325
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
    Erneux C; Van Sande J; Dumont JE; Boeynaems JM
    Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterases of human and rat gastric mucosa.
    Klotz U; Antonin KH; Bieck P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):187-90. PubMed ID: 189231
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of the cyclic adenosine 3' : 5' -monophosphate phosphodiesterase activator protein in rat heart.
    Wallace GA; Harary I
    Biochem Biophys Res Commun; 1975 Nov; 67(2):810-7. PubMed ID: 173330
    [No Abstract]   [Full Text] [Related]  

  • 19. Affinity chromatography purification of a cyclic nucleotide phosphodiesterase using immobilized modulator protein, a troponin C-like protein from brain.
    Watterson DM; Vanaman TC
    Biochem Biophys Res Commun; 1976 Nov; 73(1):40-6. PubMed ID: 187190
    [No Abstract]   [Full Text] [Related]  

  • 20. Conformational transition accompanying the binding of Ca2+ to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesterase.
    Klee CB
    Biochemistry; 1977 Mar; 16(5):1017-24. PubMed ID: 14663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.